Fujimura Akiko 藤村晶子

… Alternative Names

FJIMURA Akiko 藤村晶子

Less

Researcher Number	60892718
Affiliation (Current)	2025: 九州大学, 医学研究院, 共同研究員
Affiliation (based on the past Project Information) *help	2021 – 2024: 九州大学, 医学研究院, 共同研究員
Review Section/Research Field	Principal Investigator Basic Section 56050:Otorhinolaryngology-related Except Principal Investigator Basic Section 55010:General surgery and pediatric surgery-related
Keywords	Principal Investigator PTPN3 / HNSCC / リン酸化経路 / チロシンキナーゼ / LCN2 / 予後因子 / 癌組織浸潤リンパ球 / 抗癌剤感受性 / 扁平上皮癌 / 新規治療法開発 … More / 癌悪性形質誘導 / 浸潤 / 遊走 / 増殖 / 頭頚部癌 / 新規癌治療法開発 / 抗がん剤感受性 / 予後予測因子 / 腫瘍形成能 / 浸潤能 / 遊走能 / 増殖能 / 新規癌治療開発 / 癌悪性形質 / 頭頚部扁平上皮癌 … More Except Principal Investigator 腫瘍免疫 / CD4 / 樹状細胞 / CD8 / 細胞傷害性Tリンパ球 / 活性化リンパ球 / 癌免疫治療 / 非抗体型免疫チェックポイント阻害剤 / 癌組織浸潤リンパ球 / 新規がん免疫治療 / 薬剤スクリーニング / 低分子化合物 / CD4リンパ球 / CD8リンパ球 / 免疫チェックポイント阻害剤 / PTPN3 Less

Analysis of PTPN3-LCN2-TK phosphorylation pathway in HNSCCPrincipal Investigator
- Principal Investigator
  
  藤村晶子
- Project Period (FY)
  2024 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56050:Otorhinolaryngology-related
- Research Institution
  Kyushu University
Development of cancer immunotherapy using non-receptor type immune checkpoint inhibitor targeting PTPN3
- Principal Investigator
  
  中山和典
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 55010:General surgery and pediatric surgery-related
- Research Institution
  Kyushu University
Development of a new therapeutic strategy of head and neck squamous cell carcinoma targeting PTPN3Principal Investigator
- Principal Investigator
  
  FJIMURA Akiko
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56050:Otorhinolaryngology-related
- Research Institution
  Kyushu University

All 2023 2022 2021

All Journal Article Presentation

[Journal Article] PTPN3 could be a therapeutic target of pancreatic cancer2022
- Author(s)
  Onishi H, Iwamoto N, Sakanashi K, Koga S, Oyama Y, Yanai K, Nakamura K, Nagai S, Fujimura A, Nakayama K, Ozono K, Yamasaki A
- Journal Title
  
  Anticancer Res
  
  Volume: 42 Issue: 6 Pages: 2869-2874
- DOI
  10.21873/anticanres.15768
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21K08672, KAKENHI-PROJECT-21K08673, KAKENHI-PROJECT-21K08712, KAKENHI-PROJECT-21K08906, KAKENHI-PROJECT-21K09583, KAKENHI-PROJECT-22K08715, KAKENHI-PROJECT-20K09180, KAKENHI-PROJECT-23K24422
[Journal Article] Cancer therapy that targets the HEDGEHOG signaling pathway considering the cancer microenvironment2022
- Author(s)
  Onishi H, Nakamura K, Yanai K, Nagai S, Nakayama K, Oyama Y, Fujimura A, Ozono K, Yamasaki A
- Journal Title
  
  Oncol Rep
  
  Volume: 47(5) Issue: 5 Pages: 93-93
- DOI
  10.3892/or.2022.8304
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K22662, KAKENHI-PROJECT-20K09180, KAKENHI-PROJECT-21K08906, KAKENHI-PROJECT-21K08673, KAKENHI-PROJECT-21K08712, KAKENHI-PROJECT-21K09583, KAKENHI-PROJECT-22K08715, KAKENHI-PROJECT-23K24422
[Journal Article] PTPN3 is a potential target for a new cancer immunotherapy that has a dual effect of T cell activation and direct cancer inhibition in lung neuroendocrine tumor2021
- Author(s)
  Koga S, Onishi H, Masuda S, Fujimura A, Ichimiya S, Nakayama K, Imaizumi A, Nishiyama K, Kojima M, Miyoshi K, Nakamura K, Umebayashi M, Morisaki T, Nakamura M
- Journal Title
  
  Transl Oncol
  
  Volume: 14(9) Issue: 9 Pages: 101152-101152
- DOI
  10.1016/j.tranon.2021.101152
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K09047, KAKENHI-PROJECT-19K09124, KAKENHI-PROJECT-19K22662, KAKENHI-PROJECT-20K09180, KAKENHI-PROJECT-21K08672, KAKENHI-PROJECT-21K09583
[Journal Article] TrkB/BDNF signaling could be a new therapeutic target for pancreatic cancer2021
- Author(s)
  Oyama Y, Nagao S, Na L, Yanai K, Umebayashi M, Nakamura K, Nagai S, Fujimura A, Nakayama K, Morisaki T, Onishi H
- Journal Title
  
  Anticancer Res
  
  Volume: 41(8) Issue: 8 Pages: 4047-4052
- DOI
  10.21873/anticanres.15205
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K09124, KAKENHI-PROJECT-19K22662, KAKENHI-PROJECT-20K09180, KAKENHI-PROJECT-21K08673, KAKENHI-PROJECT-21K08712, KAKENHI-PROJECT-21K08906, KAKENHI-PROJECT-21K09583
[Presentation] 頭頸部癌に対する抗PD-1抗体薬治療におけるPTPN3阻害治療併用効果の検証2023
- Author(s)
  益田　昌吾、岩本　直也、森崎　晋史、那　　　琳、坂梨　渓太、糸山　晋作、藤村　晶子、今泉　　晃、大西　秀哉
- Organizer
  第44回癌免疫外科研究会
- Data Source
  KAKENHI-PROJECT-21K09583
[Presentation] 頭頚部癌に対するPTPN3阻害治療の検証2023
- Author(s)
  益田昌吾、岩本直也、坂梨渓太、森崎晋史、糸山晋作、藤村晶子、大西秀哉
- Organizer
  第36回　日本バイオセラピィ学会
- Data Source
  KAKENHI-PROJECT-21K09583
[Presentation] 頭頸部癌に対する抗PD-1抗体薬治療におけるPTPN3阻害治療併用効果の検証2023
- Author(s)
  益田　昌吾、岩本　直也、森崎　晋史、那　　　琳、坂梨　渓太、糸山　晋作、藤村　晶子、今泉　　晃、大西　秀哉
- Organizer
  第44回癌免疫外科研究会
- Data Source
  KAKENHI-PROJECT-22K08715
[Presentation] 頭頚部癌に対するPTPN3阻害治療の検証2023
- Author(s)
  益田昌吾、岩本直也、坂梨渓太、森崎晋史、糸山晋作、藤村晶子、大西秀哉
- Organizer
  第36回　日本バイオセラピィ学会
- Data Source
  KAKENHI-PROJECT-22K08715
[Presentation] 頭頸部癌に対する抗 PD-1 抗体薬治療における PTPN3 阻害治療併用効果の検証2022
- Author(s)
  益田昌吾、岩本直也、森崎晋史、長尾晋次郎、那琳、古賀智子、藤村晶子、今泉晃、大西秀哉
- Organizer
  第43回　癌免疫外科研究会
- Data Source
  KAKENHI-PROJECT-22K08715
[Presentation] 頭頸部癌に対する抗 PD-1 抗体薬治療における PTPN3 阻害治療併用効果の検証2022
- Author(s)
  益田昌吾、岩本直也、森崎晋史、長尾晋次郎、那琳、古賀智子、藤村晶子、今泉晃、大西秀哉
- Organizer
  第43回　癌免疫外科研究会
- Data Source
  KAKENHI-PROJECT-21K09583
[Presentation] 頭頸部癌における PTPN3 の生物学的意義の解析2022
- Author(s)
  益田昌吾、岩本直也、坂梨渓太、森崎晋史、那琳、長尾晋次郎、藤村晶子、大西秀哉
- Organizer
  第35回日本バイオセラピィ学会学術集会総会
- Data Source
  KAKENHI-PROJECT-21K09583
[Presentation] 頭頸部癌における PTPN3 の生物学的意義の解析2022
- Author(s)
  益田昌吾、岩本直也、坂梨渓太、森崎晋史、那琳、長尾晋次郎、藤村晶子、大西秀哉
- Organizer
  第35回日本バイオセラピィ学会学術集会総会
- Data Source
  KAKENHI-PROJECT-22K08715
[Presentation] 新規免疫チェックポイント分子PTPN3を標的とする新たな癌免疫治療の可能性2021
- Author(s)
  益田昌吾、古賀　智子、中山　和典、長尾　晋次郎、一宮　脩、藤村　晶子、大西　秀哉
- Organizer
  第42回癌免疫外科研究会
- Data Source
  KAKENHI-PROJECT-21K09583
[Presentation] レンバチニブとネオアンチゲン療法で PR となった外耳道腺様嚢胞癌の一例2021
- Author(s)
  藤村晶子、益田宗幸、大西秀哉、森崎隆
- Organizer
  第34回日本バイオセラピィ学会学術集会総会
- Data Source
  KAKENHI-PROJECT-21K09583
[Presentation] 頭頚部癌に対する抗 PD-1 抗体薬治療における PTPN3 阻害治療併用効果の検証2021
- Author(s)
  益田昌吾、古賀智子、岩本直也、長尾晋次郎、那琳、森崎晋史、藤村晶子、大西秀哉
- Organizer
  第34回日本バイオセラピィ学会学術集会総会
- Data Source
  KAKENHI-PROJECT-21K09583

1. 大西秀哉 (30553276)

# of Collaborated Projects: 3 results

# of Collaborated Products: 15 results
2. 中川尚志 (70274470)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
3. 小宗徳孝 (80529884)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
4. 中村勝也 (60585743)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
5. 中山和典 (30915252)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
6. 山下智大 (30645635)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
7. 大薗慶吾 (60912847)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
8. 森崎隆

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
9. 三好圭

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
10. 永井俊太郎

# of Collaborated Projects: 0 results

# of Collaborated Products: 3 results
11. 中村雅史

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
12. 山崎章生

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
13. 梁井公輔

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Fujimura Akiko 藤村 晶子

FJIMURA Akiko 藤村 晶子

Research Projects

Research Products

Co-Researchers

Analysis of PTPN3-LCN2-TK phosphorylation pathway in HNSCCPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of cancer immunotherapy using non-receptor type immune checkpoint inhibitor targeting PTPN3

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Development of a new therapeutic strategy of head and neck squamous cell carcinoma targeting PTPN3Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] PTPN3 could be a therapeutic target of pancreatic cancer2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Cancer therapy that targets the HEDGEHOG signaling pathway considering the cancer microenvironment2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] PTPN3 is a potential target for a new cancer immunotherapy that has a dual effect of T cell activation and direct cancer inhibition in lung neuroendocrine tumor2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] TrkB/BDNF signaling could be a new therapeutic target for pancreatic cancer2021

Author(s)

Journal Title

DOI

Data Source

[Presentation] 頭頸部癌に対する抗PD-1抗体薬治療におけるPTPN3阻害治療併用効 果の検証2023

Author(s)

Organizer

Data Source

[Presentation] 頭頚部癌に対するPTPN3阻害治療の検証2023

Author(s)

Organizer

Data Source

[Presentation] 頭頸部癌に対する抗PD-1抗体薬治療におけるPTPN3阻害治療併用効 果の検証2023

Author(s)

Organizer

Data Source

[Presentation] 頭頚部癌に対するPTPN3阻害治療の検証2023

Author(s)

Organizer

Data Source

[Presentation] 頭頸部癌に対する抗 PD-1 抗体薬治療における PTPN3 阻害治療併用効果の検証2022

Author(s)

Organizer

Data Source

[Presentation] 頭頸部癌に対する抗 PD-1 抗体薬治療における PTPN3 阻害治療併用効果の検証2022

Author(s)

Organizer

Data Source

[Presentation] 頭頸部癌における PTPN3 の生物学的意義の解析2022

Author(s)

Organizer

Data Source

[Presentation] 頭頸部癌における PTPN3 の生物学的意義の解析2022

Author(s)

Organizer

Data Source

[Presentation] 新規免疫チェックポイント分子PTPN3を標的とする新たな癌免疫治療の可能性2021

Author(s)

Organizer

Data Source

[Presentation] レンバチニブとネオアンチゲン療法で PR となった外耳道腺様嚢胞癌の一例2021

Fujimura Akiko 藤村晶子

FJIMURA Akiko 藤村晶子

[Presentation] 頭頸部癌に対する抗PD-1抗体薬治療におけるPTPN3阻害治療併用効果の検証2023

[Presentation] 頭頸部癌に対する抗PD-1抗体薬治療におけるPTPN3阻害治療併用効果の検証2023